Abstract
Despite the great progress that has been made in intensive care medicine, the incidence of sepsis and its sequelae has not diminished and still carries high mortality [1, 2]. Although the pathogenesis is not completely understood, sepsis is generally known to be caused by the activation of inflammatory cells and the release of endogenous humoral mediators in response to bacterial products, in particular endotoxins [3]. Evidence is slowly accumulating that excessively activated endogenous inflammatory cells and their compounds may be responsible for structural damage and functional deterioration of remote vital organ systems [4]. However, besides the activation of neutrophils and macrophages and the actions of cytokines, arachidonic acid metabolites, complement products, proteolytic enzymes and toxic oxygen radicals, impaired nutritional blood flow has been advocated as a key determinant for the development of organ dysfunction and subsequent multiple organ failure in septic shock [5, 6].
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Bone RC, Fisher CJ, Clemmer TP, Slotman GJ, Metz CA, Balk RA (1989) The methylprednisolone severe study group: Sepsis syndrome: a valid clinical entity. Crit Care Med 17:389–393.
Harris RL, Musher DM, Bloom K et al (1987) Manifestations of sepsis. Arch Intern Med 147:1895–1906.
Morrison DC, Ulevitch RJ (1978) The effects of bacterial endotoxins in host mediation systems. Am J Pathol 93:527–617.
Goris RJA (1990) Mediators of multiple organ failure. Intensive Care Med 16:S192–S196.
Thijs LG, Schneider AJ, Groeneveld ABJ (1990) The haemodynamics of septic shock. Intensive Care Med 16:S182–S186.
Kreimeier U, Ruiz-Morales M, Messmer K (1993) Comparison of the effects of volume resuscitation with dextran 60 vs Ringers’s lactate on central hemodynamics, regional blood flow, pulmonary function, and blood composition during hyperdynamic endotoxemia. Circ Shock 39:89–99.
Messmer K, Kreimeier U, Hammersen F (1988) Multiple organ failure: clinical implications to macro-and microcirculation. In: Manabe H, Zweifach BW, Messmer K (eds) Microcirculation in circulatory disorders. Springer, Berlin Heidelberg New York, pp 147–157.
Thijs LG, Groeneveld ABJ (1987) The circulatory defect of septic shock. In: Vincent JL, Thijs LG (eds) Septic shock. Springer, Berlin Heidelberg New York, pp 161–178.
Baker CC, Chaudry IH, Gaines HO, Baue AE (1983) Evaluation of factors affecting mortality rate after sepsis in murine cecal ligation and puncture model. Surgery 94:331–335.
Lang CH, Bagby GJ, Bornside GH, Vial LJ, Spitzer JJ (1983) Sustained hypermetabolic sepsis in rats: characterization of the model. J Surg Res 35:201–210.
Short BL, Gardiner WM, Walker RI, Fletcher JR, Rogers JE (1983) Rat intraperitoneal sepsis — a clinically relevant model. Circ Shock 10:351–359.
Kreimeier U, Hammersen F, Ruiz-Morales M, Yang Zh, Messmer K (1991) Redistribution of intraorgan blood flow in acute, hyperdynamic porcine endotoxemia. Eur Surg Res 23:85–99.
Wichtermann KA, Baue AE, Chaudry IA (1980) Sepsis and septic shock — a review of laboratory models and a proposal. J Surg Res 29:189–201.
Bersten AD, Gnidec AA, Rutledge FS, Sibbald WJ (1990) Hyperdynamic sepsis modifies a PEEP-mediated redistribution in organ blood flows. Am Rev Respir Dis 141:1198–1208.
Fish RE, Lang CH, Spitzer JA (1986) Regional blood flow during continuous low-dose endotoxin infusion. Circ Shock 18:267–275.
Wang P, Zhou M, Rana MW, Ba ZF, Chaudry IH (1992) Differential alterations in microvascular perfusion in various organs during early and late sepsis. Am J Physiol 263:G38–G43.
Abel FL (1989) Myocardial function in sepsis and endotoxin shock. Am J Physiol 26:R1265–R1281.
Lang CH, Bagby GJ, Ferguson JL, Spitzer JJ (1984) Cardiac output and redistribution of organ blood flow in hypermetabolic sepsis. Am J Physiol 246:R331–R337.
Parker MM, Shelhammer JH, Bacharach SL et al (1984) Profound but reversible myocardial depression in patients with septic shock. Ann Intern Med 100:483–490.
Weisel RD, Vito L, Dennis RC (1977) Myocardial depression during sepsis. Am J Surg 133:512–521.
Frey L, Kreimeier U, Schwarz G, von Hirschhausen E, Messmer K (1990) Deterioration of renal function during hyperdynamic endotoxemia correlates with redistribution of intrarenal blood flow. Eur Surg Res 22:66 (abstract).
Cunnion RE, Schaer GL, Parker MM, Natanson C, Parillo JE (1986) The coronary circulation in human septic shock. Circulation 73:637–644.
Oettinger W, Roscher R, Jonescu J, Beger HG (1986) Renal prostaglandin-release, blood flow, and function in porcine endotoxic shock. Langenbecks Arch Chir 187-190.
Nagler AL (1980) The circulatory manifestations of bacterial endotoxemia. In: Kaley G, Altura BM (eds) Microcirculation. University Park Press, Baltimore, pp 107–117.
Cryer HG, Garrison RN, Harris PD, Greenwald BH, Alsip NL (1990) Prostaglandins mediate skeletal muscle arteriole dilation in hyperdynamic bacteremia. Am J Physiol 259:H728–H734.
Cryer HM, Garrison RN, Harris PD (1988) Role of muscle microvasculature during hyperdynamic and hypodynamic phases of endotoxin shock in decerebrate rats. J Trauma 28:312–318.
Brånemark PI, Urbaschek B (1967) Endotoxins in tissue injury. Vital microscopic studies on the effect of endotoxin from E. coli on the microcirculation. Angiology 18:667–671.
Urbaschek B, Huth K, Krech HJ (1969) Endotoxin-induced microcirculatory disturbances and interaction to various metabolic parameters including the coagulation system. Bibl Anat 10:442–448.
Zweifach BW, Nagler AL, Thomas L (1956) The role of epinephrine in the reactions produced by endotoxins of gram negative bacteria. The changes produced by endotoxin in the vascular reactivity of epinephrine in the rat mesoappendix and the isolated, perfused rabbit ear. J Exp Med 104:881–896.
Bond RF (1985) Peripheral circulatory responses to endotoxin. In: Hinshaw LB (ed) Pathophysiology of endotoxin. Elsevier Science, Amsterdam, pp 36–75 (Handbook of endotoxin, vol 2).
Lübbe AS, Garrison RN, Cryer HM, Alsip NL, Harris PD (1992) EDRF as a possible mediator of sepsis-induced arteriolar dilation in skeletal muscle. Am J Physiol 262:H880–H887.
Wright CE, Rees DD, Moncada S (1992) Protective and pathological role of nitric oxide in endotoxin shock. Cardiovasc Res 26:48–57.
Hollenberg SM, Cunnion RE, Parrillo JE (1992) Effect of septic serum on vascular smooth muscle: In vitro studies using rat aortic rings. Crit Care Med 20:993–998.
McKenna TM (1992) Recovery of vascular tissue contractile function during sustained endotoxin exposure. Am J Physiol 263:H1628–H1631.
Baker CH, Sutton ET, Zhou Z, Dietz JR (1990) Microvascular vasopressin effects during endotoxin shock in the rat. Circ Shock 30:81–95.
Balis JU, Rappaport ES, Gerber L, Fareed J, Buddingh F, Messmore HL (1978) A primate model for prolonged endotoxin shock. Blood-vascular reactions and effects of glucocorticoid treatment. Lab Invest 38:511–523.
McCuskey RS (1993) Hepatic microvascular responses to endotoxinemia and sepsis. Prog Appl Microcirc 19:76–84.
Vollmar B, Glasz J, Senkel A, Menger MD, Messmer K (1993) Role of leukocytes in the initial hepatic microvascular response to endotoxemia. Zentralbl Chir 118:691–696.
Gutierrez G, Lund N, Palizas F (1991) Rabbit skeletal muscle PO2 during hypodynamic sepsis. Chest 99:224–229.
Sugino K, Dohi K, Yamada K, Kawasaki T (1987) The role of lipid peroxidation in endotoxin-induced hepatic damage and the protective effect of antioxidants. Surgery 101:746–752.
Nolan JP (1981) Endotoxin, reticuloendothelial function, and liver injury. Hepatology 1:458–465.
Schaefer CF, Biber B, Lerner MR, Vliet J-V, Fagraeus L (1991) Rapid reduction of intestinal cytochrome a1a3 during lethal endotoxemia. J Surg Res 51:382–391.
Kawasaki K, Galla TJ, Lehr HA, Meßmer K (1990) Endotoxin verstärkt das Leukozy-tensticking in der Mikrozirkulation des postischämischen Skelettmuskels. Langenbecks Arch Chir Forum 90:29–32.
Snapper JR, Bernard GR, Hinson JM, Hutchinson AA, Loyd JE, Ogletree ML, Brigham KL (1983) Endotoxemia-induced leukopenia in sheep. Am Rev Respir Dis 127:306–309.
Grisham MB, Everse J, Janssen HF (1988) Endotoxemia and neutrophil infiltration in vivo. Am J Physiol 254: H1017–H1022.
Dahinden C, Galanos C, Fehr J (1983) Granulocyte activation by endotoxin I. J Immunol 130:857–862.
Issekutz AC, Megyeri P, Issekutz TB (1987) Role for macrophage products in endotoxin-induced polymorphonuclear leukocyte accumulation during inflammation. Lab Invest 56:49–59.
Wilson ME (1985) Effects of bacterial endotoxins on neutrophil function. Rev Infect Dis 7:404–418.
Meyrick BO (1986) Endotoxin-mediated pulmonary endothelial cell injury. Federation Proc 45:19–24.
Jaeschke H, Farhood A, Smith CW (1991) Neutrophil-induced liver cell injury in endotoxin shock is a CD11b/CD18-dependent mechanism. Am J Physiol 261:G1051–G1056.
Simms HH, D’Amico R (1991) Increased PMN CD11b/CD18 expression following posttraumatic ARDS. J Surg Res 50:362–367.
Windsor ACJ, Walsh CJ, Mullen PG et al (1993) Tumor necrosis factor-α blockade prevents neutrophil CD18 receptor upregulation and attenuates acute lung injury in porcine sepsis without inhibition of neutrophil oxygen radical generation. J Clin Invest 91:1459–1468.
Engelberts I, Samyo SK, Leuwenberg JFM, van der Linden C, Buurman WA (1992) A role of ELAM-1 in the pathogenesis of MOF during septic shock. J Surg Res 53:136–144.
Heflin AC, Brigham KL (1981) Prevention of granulocyte depletion of increased vascular permeability of sheep lung following endotoxemia. J Clin Invest 68:1253–1260.
Koike K, Moore FA, Moore EE, Poggetti RS, Tudre RM, Banerjee A (1992) Endotoxin after gut ischemia/reperfusion causes irreversible lung injury. J Surg Res 52:656–662.
Matsuda T, Rubinstein I, Robbins RA, Koyama S, Joyner WL, Rennard SI (1991) Role of neutrophils in endotoxin-mediated microvascular injury in hamsters. J Appl Physiol 71:307–313.
Fantone JC, Ward PA (1982) Role of oxygen-derived free radicals and metabolites in leukocyte-dependent inflammatory reactions. Am J Pathol 107:397–418.
Bautista AP, Spitzer JJ (1990) Superoxide anion generation by in situ perfused rat liver: effect of in vivo endotoxin. Am J Physiol 259: G907–G912.
Mayer AMS, Spitzer JA (1991) Continuous infusion of escherichia coli endotoxin in vivo primes in vitro superoxide anion release in rat polymorphonuclear leukocytes and Kupffer cells in a time-dependent manner. Infect Immun 59:4590–4598.
Mavier P, Preaux A-M, Guigui B, Lescs M-C, Zafrani E-S, Dhumeaux D (1988) In vitro toxicity of polymorphonuclear neutrophils to rat hepatocytes: evidence for a proteinase-mediated mechanism. Hepatology 8:254–258.
Hewett JA, Schultze E, VanCise S, Roth RA (1992) Neutrophil depletion protects against liver injury from bacterial endotoxin. Lab Invest 68:347–361.
Mallick AA, Ishizaka A, Stephens KE, Hatherill JR, Tazelaar HD, Raffin TA (1989) Multiple organ damage caused by tumor necrosis factor and prevented by prior neutrophil depletion. Chest 95:1114–1120.
Arredondo MI, Kampschmidt RF (1962) Effect of endotoxins on phagocytic activity of the reticuloendothelial system of the rat. PSEBM 112:78–81.
Pilaro AM, Laskin DL (1986) Accumulation of activated mononuclear phagocytes in the liver following lipopolysaccharides treatment of rats. J Leukoc Biol 40:29–41.
Decker K (1990) Biologically active products of stimulated liver macrophages (Kupffer cells). Eur J Biochem 192:245–261.
Monden K, Arn S, Itai S et al (1991) Enhancement and hepatocyte-modulating effect of chemical mediators and monokines produced by hepatic macrophages in rats with induced sepsis. Res Exp Med 191:177–187.
Karck U, Peters T, Decker K (1988) The release of tumor necrosis factor from endo-toxin-stimulated rat Kupffer cells is regulated by prostaglandin E2 and dexamethasone. J Hepatol 7:352–361.
Dinarello CA (1984) Interleukin-1. Rev Infect Dis 6:51–95.
Callery MP, Mangino MJ, Kamei T, Flye MW (1990) Interleukin-6 production by endotoxin-stimulated Kupffer cells is regulated by prostaglandin E2. J Surg Res 48:523–527.
Assoian RK, Fleurdelys BE, Stevenson HC et al. (1987) Expression and secretion of type β transforming growth factor by activated human macrophages. Proc Natl Acad Sci USA 84:6020–6024.
Remick DG, Kunkel RG, Larrick JW, Kunkel SL (1987) Acute in vivo effects of human recombinant tumor necrosis factor. Lab Invest 56:583–590.
Bevilacqua MP, Pober JS, Majeau GR, Fiers W, Cotran RS, Gimbrone MA (1986) Recombinant tumor necrosis factor induces procoagulant activity in cultured human vascular endothelium: characterization and comparison with the actions of interleukin 1. Proc Natl Acad Sci USA 83:4533–4537.
Stadler J, Billiar TR, Curran RD, Stuehr DJ, Ochoa JB, Simmons RL (1991) Effect of exogenous and endogenous nitric oxide on mitochondrial respiration of rat hepatocytes. Am J Physiol 260:C910–C916.
Braquet P, Hosford D (1989) The potential role of platelet-activating factor (PAF) in shock, sepsis and adult respiratory distress syndrome (ARDS). Prog Clin Biol Res 308:425–439.
Bevilacqua MP, Pober JS, Mendrick DL, Cotran RS, Gimbrone MA (1987) Identification of an inducible endothelial-leukocyte adhesion molecule. Proc Natl Acad Sci USA 84:9238–9242.
Pober JS, Gimbrone MA, Lapierre LA, Mendrick DL, Fiers W, Rothlein R, Springer TA (1986) Overlapping patterns of activation of human endothelial cells by interleukin 1, tumor necrosis factor, and immune interferon. J Immunol 137:1893–1896.
Drake WT, Issekutz AC (1993) Transforming growth factor-β1 enhances polymorphonuclear leukocyte accumulation in dermal inflammation and transendotheh’al migration by a priming action. Immunology 78:197–204.
Reibman J, Meixler S, Lee TL et al (1991) Transforming growth factor β1, a potent chemoattractant for human neutrophils, bypasses classic signal-transduction pathway. Proc Natl Acad Sci USA 88:6805–6809.
Wiseman DM, Polverini PJ, Kamp DW, Leibovich SJ (1988) Transforming growth factor-beta (TGFβ) is chemotactic for human monocytes and induces their expression of angiogenic activity. Biochem Biophys Res Commun 157:793–800.
Fiorentino DF, Bond MW, Mosmann TR (1989) Two types of mouse T helper cell: IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones. J Exp Med 170:2081–2095.
O’Garra A, Chang R, Hastings R, Go N, Haughton G, Howard M (1992) Ly1 B (B-1) cells are the main source of B-cell derived IL-10. Eur J Immunol 22:711–717.
de Waal Malefyt R, Abrams J, Bennett B, Figdor C, de Vries JE (1991) IL-10 inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes. J Exp Med 174:1209–1220.
Fiorentino DF, Zlotnik A, Mosmann TR, Howard M, O’Garra A (1991) IL-10 inhibits cytokine production by activated macrophages. J Immunol 147:3815–3822.
Howard M, Muchamuel T, Andrade S, Menon S (1993) Interleukin 10 protects mice from lethal endotoxemia. J Exp Med 177:1205–1208.
Ogletree ML, Oates JA, Brigham KL, Hubbard WC (1982) Evidence for pulmonary release of 5-hydroxyeicosatetraenoic acid (5-HETE) during endotoxemia in unanesthetized sheep. Prostaglandins 23:459–468.
Dahlen SE, Björk J, Hedqvist P, Arfors KE, Hammarström S, Lindgren JA, Samuelsson B (1981) Leukotriene promotes plasma leakage and leukocyte adhesion in postcapillary venules: in vivo effects with relevance to the acute inflammatory response. Proc Natl Acad Sci USA 78:3887–3891.
Ford-Hutchinson AW, Bray MA, Doig MV, Shipley ME, Smith MJH (1980) Leukotriene B4, a potent chemokinetic and aggregating substance released from polymorphonuclear leukocytes. Nature 286:264–265.
Hua XY, Dahlen SE, Lundberg JM, Hammarström S, Hedqvist P (1985) Leukotrienes C4, D4, and E4 cause widespread and extensive plasma extravasation in the guinea pig. Naunyn-Schmiedebergs Arch Pharmacol 330:136–141.
Piper PJ (1984) Formation and action of leukotrienes. Physiol Rev 64:744–761.
Bone RC (1992) Inhibitors of complement and neutrophils: a critical evaluation of their role in the treatment of sepsis. Crit Care Med 20:891–898.
Harkema JM, Chaudry IH (1992) Magnesium-adenosine triphosphate in the treatment of shock, ischemia and sepsis. Crit Care Med 20:263–275.
Alexander HR, Doherty GH, Buresh CM, Venzon DJ, Norton JA (1991) A recombinant human receptor antagonist to interleukin 1 improves survival after lethal endotoxemia in mice. J Exp Med 173:1029–1032.
Beutler B, Milsark IW, Cerami A (1985) Passive immunization against cachectin/tumor necrosis factor protects mice from lethal effect of endotoxin. Science 229:869–871.
Kopaniak MM, Movat HZ (1983) Kinetics of acute inflammation induced by Escherichia coli in rabbits II. The effect of hyperimmunization, complement depletion, and depletion of leukocytes. Am J Pathol 110:13–29.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1994 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Menger, M.D., Vollmar, B., Messmer, K. (1994). Sepsis and Nutritional Blood Flow. In: Reinhart, K., Eyrich, K., Sprung, C. (eds) Sepsis. Update in Intensive Care and Emergency Medicine, vol 18. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-85036-3_12
Download citation
DOI: https://doi.org/10.1007/978-3-642-85036-3_12
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-85038-7
Online ISBN: 978-3-642-85036-3
eBook Packages: Springer Book Archive